论文部分内容阅读
目的探讨析CT与MRI在肝癌诊断中的价值。方法对我院2008年3月-2010年3月共76例确诊为肝癌的患者进行分组分析,并观察CT和MRI的诊断结果。结果 CT的敏感性为97.5%(95%CI:95.3-100%),阳性预测值为94.87%(95%CI:92.27-98.53%);MRI敏感性为91.66%(95%CI:88.36-94.58%),阳性预测值为90.90%(95%CI:87.22-93.45%),两组之间的敏感性和阳性预测值有统计学差异(P<0.05)。结论在诊断肝癌的临床过程中,CT的价值要明显高于MRI。
Objective To explore the value of CT and MRI in the diagnosis of liver cancer. Methods A total of 76 patients diagnosed with hepatocellular carcinoma from March 2008 to March 2010 in our hospital were divided into groups, and the diagnostic results of CT and MRI were observed. Results The sensitivity of CT was 97.5% (95% CI: 95.3-100%), the positive predictive value was 94.87% (95% CI: 92.27-98.53%). The sensitivity of CT was 91.66% (95% CI: 88.36-94.58 %). The positive predictive value was 90.90% (95% CI: 87.22-93.45%). There was a significant difference between the two groups in the sensitivity and positive predictive value (P <0.05). Conclusion In the clinical diagnosis of liver cancer, the value of CT should be significantly higher than that of MRI.